Jones Day

Size of Organization: 2084

Icon for Featured Peer Review Rated Lawyer at this firm

Martindale-Hubbell has augmented a firm's provided information with third-party sourced data to present a more comprehensive overview of the firm's expertise:

Law Firm Snapshot

U.S. Federal Litigation Activity

Source: U.S. Federal Civil District Court Databases. Powered by LexisNexis atVantage

Highest number of cases by Jones Day:
Banking Law (176 cases in past two years)

U.S. Federal Litigation Activity Details

Transactional Activity

Source: FactSet Research Systems, Inc. Powered by LexisNexis atVantage

Total number of Mergers & Aquisitions by Jones Day:
692 (in past two years)

Transactional Activity Details

Peer Review Ratings

Total number of Peer Review Rated lawyers of Jones Day: 337

Peer Review Ratings Details

Articles by Jones Day on Martindale.com

A Therapy against National Barriers--Liberalization of European Pharmaceutical Advertising
Christian B. Fulda, Alastair J. McCulloch, Evelyne Friedel, Anna Rosa Cosi, Marta Delgado, May 8, 2008
In retrospect, the European pharmaceutical industry may well wonder why it owes the liberalization of advertising to a ginseng product.

China's Draft Merger Review Regulations
Peter J. Wang, Yizhe Zhang, May 8, 2008
China's State Council has published draft Regulations on Notifications of Concentrations of Undertakings (the "Draft Regulations") for public comment.

China's Draft Merger Review Regulations
Peter J. Wang, Yizhe Zhang, April 21, 2008
China's State Council has published draft Regulations on Notifications of Concentrations of Undertakings (the "Draft Regulations") for public comment. These are intended to implement the relatively general merger control provisions in China's new Anti-Monopoly Law ("AML"), which...

View more articles